Smoking pathophysiology: Difference between revisions
Jump to navigation
Jump to search
Usama Talib (talk | contribs) Created page with "__NOTOC__ {{Smoking}} {{CMG}}; {{AE}} ==Overview== ==Pathophysiology== ==References== {{Reflist|2}} {{WH}} {{WS}}" |
|||
| Line 6: | Line 6: | ||
==Pathophysiology== | ==Pathophysiology== | ||
===Genetics=== | |||
*CYP2A6 is the gene coding for enzymes that metabolize nicotine. Polymorphisms in the gene are influence the nicotine addictive behavior.<ref name="pmid28507465">{{cite journal| author=López-Flores LA, Pérez-Rubio G, Falfán-Valencia R| title=Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction. | journal=EXCLI J | year= 2017 | volume= 16 | issue= | pages= 174-196 | pmid=28507465 | doi=10.17179/excli2016-847 | pmc=5427481 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=28507465 }} </ref> | |||
==References== | ==References== | ||
Revision as of 15:58, 31 May 2017
|
Smoking Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
Pathophysiology
Genetics
- CYP2A6 is the gene coding for enzymes that metabolize nicotine. Polymorphisms in the gene are influence the nicotine addictive behavior.[1]
References
- ↑ López-Flores LA, Pérez-Rubio G, Falfán-Valencia R (2017). "Distribution of polymorphic variants of CYP2A6 and their involvement in nicotine addiction". EXCLI J. 16: 174–196. doi:10.17179/excli2016-847. PMC 5427481. PMID 28507465.